Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the NF-κB signaling.
Activation of adenosine A3 receptor (A3AR) can regulate inflammation, but how A3AR activation regulates colonic mucosal inflammation in ulcerative colitis (UC) remains unclear. This study aimed at examining A3AR expression and investigating the effect of A3AR activation on ex vivo cytokine expression and nuclear factor-kappa B (NF-κB) signaling in colonic mucosa. Colonic mucosal biopsied tissues from 18 UC patients and 11 healthy subjects were tested for their A3AR expression by immunofluorescence, quantitative RT-PCR and Western blot. Following treatment with, or without, 2-Cl-IB-MECA, an A3AR agonist for 24 hours, the secreted TNF-α and IL-1β by the cultured colonic mucosal tissues were quantified by ELISA. The colonic mucosal epithelia were dissected and treated with, or without 2-Cl-IB-MECA for 24 hours. The NF-κBp65 protein and its distribution in the cultured colonic epithelia were examined by immunofluorescence and Western blot. Compared to healthy subjects, down-regulated A3AR expression and up-regulated TNF-α and IL-1β production and the nuclear NF-κBp65 protein were observed in the UC colonic mucosa. Activation of A3AR by 2-Cl-IB-MECA significantly decreased TNF-α and IL-1β production and attenuated the NF-κBp65 activation in colonic tissues from UC patients. A3AR activation inhibited inflammation by mitigating pro-inflammatory cytokine production and the NF-κB signal activation in colonic mucosa of UC patients. A3AR activation may play a role in the pathogenesis of UC. This article is protected by copyright. All rights reserved.